Balanced news tone
News Sentiment
MSLE sentiment intelligence
Satellos Bioscience Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
51 relevant articles
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+31.9% over one week, +70.3% over four weeks, trend inactive, and near fair-value range.
Satellos Bioscience DMD Drug Shows Early Promise in 6-Month Study Update
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
82/100 classification
One-week reaction
31.9%
Price confirming higher
Trend fit
Trend inactive
70.3% over four weeks
Fair value
21.2%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
8
Neutral
40
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
StockStory
Direct company coverage
GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- StockStory
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Seeking Alpha
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
TradingView
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Barchart.com
Direct company coverage
This ‘Alpha Male’ Stock Is Profiting as the Strait of Hormuz Remains Closed. Should You Buy It Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Mar 2026 07:00
- Source
- Barchart.com
Market source
Direct company coverage
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- Market source
Kavout | AI
Direct company coverage
Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Feb 2026 09:53
- Source
- Kavout | AI
TIKR.com
Direct company coverage
Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 25 Feb 2026 08:00
- Source
- TIKR.com
Barron's
Direct company coverage
This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Barron's
Market source
Direct company coverage
Satellos price target raised to $40 from $5 at Oppenheimer
- Tone
- Positive 64/100
- Event
- Analyst action
- Published
- 11 Feb 2026 08:00
- Source
- Market source
Mintz
Direct company coverage
Mintz Advises Satellos Bioscience in Its US$57.2 Million Initial US Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2026 08:00
- Source
- Mintz
BioSpace
Direct company coverage
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2026 08:00
- Source
- BioSpace
Stocktwits
Direct company coverage
Why MSLE Stock Gave Up All Nasdaq Debut Gains And Fell 8% After Hours
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Feb 2026 08:00
- Source
- Stocktwits
Zacks Investment Research
Direct company coverage
What is the current Price Target and Forecast for Satellos Bioscience Inc. (MSLE)
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 08 Feb 2026 22:26
- Source
- Zacks Investment Research
CNN
Direct company coverage
symbol__ Stock Quote Price and Forecast
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 07 Feb 2026 19:58
- Source
- CNN
Business Wire
Direct company coverage
Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- Business Wire
Finimize
Direct company coverage
Satellos Bioscience Priced A $50 Million Stock Sale As It Lists On Nasdaq
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- Finimize
Business Wire
Direct company coverage
Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2026 08:00
- Source
- Business Wire
Investing News Network
Direct company coverage
Satellos Announces Share Consolidation in Connection with Proposed Nasdaq Listing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jan 2026 08:00
- Source
- Investing News Network
Barron's
Direct company coverage
UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn’t the Only Problem.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jan 2026 08:00
- Source
- Barron's